Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2019

Causes and predictors of 6-month readmission rate after drug eluting stent in the contemporary era- A nationwide analysis

Presenter: Syed Zaid

September 29, 2019

Presentation TCT 2019

Maximizing CTO PCI Durability (Optimizing Vessel Healing, Avoiding Stent Fractures, Using Adjunctive Technologies Including Drug-Eluting Balloons)

Presenter: Paul Knaapen

September 28, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

Presenter: Lei Song

September 25, 2019

Presentation TCT 2019

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

Presenter: Robert-Jan Van Geuns

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 55: Incidence, Predictors, and Clinical Implications of Stent Optimization on Intravascular Ultrasound After New-generation Drug-eluting Stent Implantation for Diffuse Long Coronary Stenotic Lesions

Presenter: Byeong-Keuk Kim

September 25, 2019

Presentation TCT 2019

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

Presenter: Junjie Zhang

September 25, 2019

Presentation TCT 2019

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

Presenter: Takahiro Jimba

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Binita Shah

September 25, 2019

Presentation TCT 2019

Drug-Eluting Stent Platforms and Outcomes 2019

Presenter: Roberto Diletti

September 25, 2019

Presentation EuroPCR 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Presenter: Clemens von Birgelen

May 21, 2019

Presentation EuroPCR 2019

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Presenter: Raban Jeger

May 20, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation SIF 2019

PCI vs. CABG for Multivessel CAD

Presenter: Sripal Bangalore

March 28, 2019

Advertisement

Causes and predictors of 6-month readmission rate after drug eluting stent in the contemporary era- A nationwide analysis

Maximizing CTO PCI Durability (Optimizing Vessel Healing, Avoiding Stent Fractures, Using Adjunctive Technologies Including Drug-Eluting Balloons)

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

TCT 48: Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial) : Very late device thrombosis while on extended DAPT

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 55: Incidence, Predictors, and Clinical Implications of Stent Optimization on Intravascular Ultrasound After New-generation Drug-eluting Stent Implantation for Diffuse Long Coronary Stenotic Lesions

TCT 29: Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: subgroup analysis from ULTIMATE trial

TCT 44: Impact of Stent Edge Hinging on Chronic Neointimal Hyperplasia after Newer Generation Drug-Eluting Stent Placement in RCA

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Update: Drug-Eluting Stents

PCI vs. CABG for Multivessel CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content